Finance Watch: As Cash Dwindles, Biotechs Cut Costs, Sell Assets, Merge, Assess Options

Workforce Reductions At Outlook, Editas, Cellectar

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.